According to Lok Sabha on Friday, the National Licensing Authority of Uttarakhand has approved the use of coronil pills as a supportive measure for the treatment of Covid19 without the need for treatment based on the recommendations of the review committee established by the AYUSH Ministry.
The Minister of Health Bharati Pravin Pavar stated in a written response that the Interdisciplinary Technical Review Committee (ITRC) established by the AYUSH Ministry has reviewed the application of the Patanjali Research Foundation to “renew the AYUSH license for Divya Coronil tablets” and “pass” the immunization The booster “to “COVID19 drugs”.
The report stated that the committee has proposed the use of tablets as a support measure in response to Covid.
“The application titled ‘Updating AYUSH license for Divya Coronil tablet from Immunity booster to Medicine for Covid-19’ submitted by Patanjali Research Foundation Trust, Haridwar, Uttarakhand to this Ministry, was placed before the ITRC on October 27, 2020 for examination of the applications/claims on patent and propriety (P&P) ASU&H medicines with new indications or repurposing of licensed P&P, ASU&H medicines for Covid-19,” Pawar said in her reply.
More Stories
Raksha Mantri Rajnath Singh will commence his four-day US tour on August 23rd
Arvind Kejriwal was sent in judicial prison till April 15 in the instance of the liquor policy
CR Kesavan appointed As party’s new National Spokesperson